House Oversight Opens Investigation Into Federal Fentanyl Policy
Empower Oversight president Tristan Leavitt made the following statement after Chairman James Comer announced an investigation into the Drug Enforcement Administration’s walking of fentanyl and the policy that allowed it. Empower Oversight represents the whistleblower, DEA Special Agent David Howell, who first brought this policy to light. “The true cost of the DEA’s fentanyl walking …